Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis - PubMed (original) (raw)
Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis
D Franchimont et al. Gut. 2004 Jul.
Abstract
Background and aims: Elicitation of an innate immune response to bacterial products is mediated through pattern recognition receptors (PRRs) such as the toll-like receptors (TLRs) and the NODs. The recently characterised Asp299Gly polymorphism in the lipopolysaccharide (LPS) receptor TLR4 is associated with impaired LPS signalling and increased susceptibility to Gram negative infections. We sought to determine whether this polymorphism was associated with Crohn's disease (CD) and/or ulcerative colitis (UC).
Methods: Allele frequencies of the TLR4 Asp299Gly polymorphism and the three NOD2/CARD15 polymorphisms (Arg702Trp, Gly908Arg, and Leu1007fsinsC) were assessed in two independent cohorts of CD patients (cohort 1, n = 334; cohort 2, n = 114), in 163 UC patients, and in 140 controls. A transmission disequilibrium test (TDT) was then performed on 318 inflammatory bowel disease (IBD) trios.
Results: The allele frequency of the TLR4 Asp299Gly polymorphism was significantly higher in CD (cohort 1: 11% v 5%, odds ratio (OR) 2.31 (95% confidence interval (CI) 1.28-4.17), p = 0.004; and cohort 2: 12% v 5%, OR 2.45 (95% CI 1.24-4.81), p = 0.007) and UC patients (10% v 5%, OR 2.05 (95% CI 1.07-3.93), p = 0.027) compared with the control population. A TDT on 318 IBD trios demonstrated preferential transmission of the TLR4 Asp299Gly polymorphism from heterozygous parents to affected children (T/U: 68/34, p = 0.01). Carrying polymorphisms in both TLR4 and NOD2 was associated with a genotype relative risk (RR) of 4.7 compared with a RR of 2.6 and 2.5 for TLR4 and NOD2 variants separately.
Conclusion: We have reported on a novel association of the TLR4 Asp299Gly polymorphism with both CD and UC. This finding further supports the genetic influence of PRRs in triggering IBD.
Figures
Figure 1
(A) Allele frequencies for the NOD2 variants (Arg702Trp, Gly908Arg, and Leu1007fsinsC) and the toll-like receptor 4 (TLR4) Asp299Gly polymorphism in the Crohn’s disease (CD) cohort 1, CD cohort 2, ulcerative colitis (UC) cohort, and controls. (B) Allele frequencies for the CD14 C −260T promoter polymorphism in the four groups.
Comment in
- Toll-like receptor 4 gene in IBD: further evidence for genetic heterogeneity in Europe.
Arnott ID, Ho GT, Nimmo ER, Satsangi J. Arnott ID, et al. Gut. 2005 Feb;54(2):308; author reply 309. Gut. 2005. PMID: 15647200 Free PMC article. No abstract available. - The toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn's disease without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathway.
Ouburg S, Mallant-Hent R, Crusius JB, van Bodegraven AA, Mulder CJ, Linskens R, Peña AS, Morré SA. Ouburg S, et al. Gut. 2005 Mar;54(3):439-40. doi: 10.1136/gut.2004.051383. Gut. 2005. PMID: 15710998 Free PMC article. No abstract available.
Similar articles
- Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A, Ikonomopoulos J, Gorgoulis VG. Gazouli M, et al. World J Gastroenterol. 2005 Feb 7;11(5):681-5. doi: 10.3748/wjg.v11.i5.681. World J Gastroenterol. 2005. PMID: 15655821 Free PMC article. - The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, Dambacher J, Seiderer J, Tillack C, Konrad A, Crispin A, Göke B, Lohse P, Ochsenkühn T. Brand S, et al. Inflamm Bowel Dis. 2005 Jul;11(7):645-52. doi: 10.1097/01.mib.0000168372.94907.d2. Inflamm Bowel Dis. 2005. PMID: 15973118 - Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease.
Feki S, Bouzid D, Abida O, Chtourou L, Elloumi N, Toumi A, Hachicha H, Amouri A, Tahri N, Masmoudi H. Feki S, et al. J Dig Dis. 2017 Nov;18(11):625-633. doi: 10.1111/1751-2980.12552. J Dig Dis. 2017. PMID: 29055077 - [Inflammatory bowel diseases: an immunological approach].
Sepúlveda SE, Beltrán CJ, Peralta A, Rivas P, Rojas N, Figueroa C, Quera R, Hermoso MA. Sepúlveda SE, et al. Rev Med Chil. 2008 Mar;136(3):367-75. Epub 2008 Jun 3. Rev Med Chil. 2008. PMID: 18575665 Review. Spanish. - Genetic and pathogenetic insights into inflammatory bowel disease.
Pallone F, Blanco Gdel V, Vavassori P, Monteleone I, Fina D, Monteleone G. Pallone F, et al. Curr Gastroenterol Rep. 2003 Dec;5(6):487-92. doi: 10.1007/s11894-003-0038-2. Curr Gastroenterol Rep. 2003. PMID: 14602058 Review.
Cited by
- The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
Figueroa L, Xiong Y, Song C, Piao W, Vogel SN, Medvedev AE. Figueroa L, et al. J Immunol. 2012 May 1;188(9):4506-15. doi: 10.4049/jimmunol.1200202. Epub 2012 Apr 2. J Immunol. 2012. PMID: 22474023 Free PMC article. - Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology.
Yu LC, Wang JT, Wei SC, Ni YH. Yu LC, et al. World J Gastrointest Pathophysiol. 2012 Feb 15;3(1):27-43. doi: 10.4291/wjgp.v3.i1.27. World J Gastrointest Pathophysiol. 2012. PMID: 22368784 Free PMC article. - Role of TLR4 rs4986790A>G and rs4986791C>T Polymorphisms in the Risk of Inflammatory Bowel Disease.
Ao R, Wang Y, Zhnag DR, Du YQ. Ao R, et al. Gastroenterol Res Pract. 2015;2015:141070. doi: 10.1155/2015/141070. Epub 2015 May 18. Gastroenterol Res Pract. 2015. PMID: 26089865 Free PMC article. Review. - Advances in the genetics of inflammatory bowel disease.
Cho JH. Cho JH. Curr Gastroenterol Rep. 2004 Dec;6(6):467-73. doi: 10.1007/s11894-004-0068-4. Curr Gastroenterol Rep. 2004. PMID: 15527676 Review. - Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients.
Braat H, Stokkers P, Hommes T, Cohn D, Vogels E, Pronk I, Spek A, van Kampen A, van Deventer S, Peppelenbosch M, Hommes D. Braat H, et al. J Mol Med (Berl). 2005 Aug;83(8):601-9. doi: 10.1007/s00109-005-0685-x. Epub 2005 Jul 12. J Mol Med (Berl). 2005. PMID: 16010583
References
- Elson CO, Cong Y, Brandwein S, et al. Experimental models to study molecular mechanisms underlying intestinal inflammation. Ann N Y Acad Sci 1998;859:85–95. - PubMed
- Rutgeerts P , Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileum. Lancet 1991;338:771–4. - PubMed
- Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417–29. - PubMed
- Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn’s disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002;123:689–99. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical